You turn to us for voices you won't hear anywhere else.

Sign up for Democracy Now!'s Daily Digest to get our latest headlines and stories delivered to your inbox every day.

HHS Nominee Tom Price Faces Accusations of Insider Trading

HeadlineJan 17, 2017

Donald Trump’s nominee for Health and Human Services secretary, Georgia Congressmember Tom Price, invested thousands of dollars in a medical device maker shortly before introducing a bill to benefit the company. That’s according to CNN, which reported Monday that Rep. Price purchased shares of Zimmer Biomet last March—less than a week before introducing the HIP Act. The legislation would have delayed regulations sure to cut into the company’s profits. Senate Minority Leader Chuck Schumer this week called for the Office of Congressional Ethics to investigate whether Rep. Price violated the STOCK Act, which restricts insider trading by members of Congress.

The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to democracynow.org. Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.
Make a donation
Top